Name of the Procedure:

Parkinson's Disease Measures Group (G8903)

Summary

The Parkinson's Disease Measures Group is a set of healthcare quality metrics designed to monitor and improve the care provided to patients with Parkinson's disease. This involves evaluating various aspects of patient management, including medication, physical therapy, and overall patient outcomes.

Purpose

The purpose of the Parkinson's Disease Measures Group is to enhance the quality of care for patients suffering from Parkinson's disease. The goals are to ensure appropriate management of symptoms, improve quality of life, and track the effectiveness of various treatment modalities.

Indications

• Diagnosis of Parkinson's disease
• Monitoring progression of Parkinson's disease
• Evaluating the effectiveness of current treatment regimens
• Ensuring adherence to best practice guidelines for Parkinson's disease management

Preparation

• Patients may need to provide a comprehensive medical history.
• Medication lists, including any over-the-counter drugs and supplements, should be reviewed.
• Recent lab tests or imaging results pertinent to Parkinson's disease may be required.

Procedure Description

1. The healthcare provider will first confirm the diagnosis of Parkinson's disease.
2. The provider will then assess various metrics related to the patient's disease state and treatment plan.
3. These metrics may include symptom severity, medication adherence, physical function, and overall well-being.
4. Standardized tools and questionnaires are often used for assessment.
5. Data is collected and analyzed to identify areas needing improvement.

Duration

The entire assessment process typically takes about 30-60 minutes, depending on the complexity of the case.

Setting

This procedure is generally performed in an outpatient setting, such as a neurology clinic or a specialized Parkinson's disease center.

Personnel

• Neurologist
• Nurse or medical assistant
• Physical therapist (optional for specific assessments)
• Data analyst (for metric evaluation)

Risks and Complications

• Minimal risks as this is a non-invasive procedure.
• Potential for inaccurate results if the patient does not provide complete or accurate information.
• Misinterpretation of data may lead to suboptimal treatment decisions.

Benefits

• Improved management of Parkinson's disease symptoms.
• Enhanced quality of life for patients.
• Ability to track disease progression and treatment effectiveness.
• Personalized treatment adjustments based on assessed metrics.

Recovery

• No recovery time needed as this is a non-invasive assessment.
• Patients might be given recommendations for follow-up care or adjustments to their treatment plan.

Alternatives

• Standard clinical examinations without the structured metrics.
• Alternative checklist and assessment tools not specific to the Parkinson's Disease Measures Group.
• Pros include less time required for standard examinations, but the cons are potentially missing out on detailed metrics that could optimize care.

Patient Experience

Patients will mainly interact with their healthcare provider through a series of interviews, questionnaires, and possibly physical assessments. These evaluations are designed to be as comfortable and straightforward as possible. Pain management is not typically necessary, but patients are encouraged to report any discomfort or issues during their assessments.